NASDAQ: DALS - DA32 Life Science Tech Acquisition Corp.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Financials

Share chart DA32 Life Science Tech Acquisition Corp.


About DA32 Life Science Tech Acquisition Corp.

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.


IPO date 2021-07-28
ISIN US23312M1062
Industry Capital Markets
Sector Financials
Валюта usd
Валюта отчета usd
Цена ао 10.32
Change price per day: 0% (10.32)
Change price per week: 0% (10.32)
Change price per month: 0% (10.32)
Change price per 3 month: 0% (10.32)
Change price per half year: 0% (10.32)
Change price per year: 0% (10.32)
Change price per 3 year: +6.61% (9.68)
Change price per year to date: 0% (10.32)

Underestimation

Title Value Grade
P/S 0 0
P/BV 1.06 9
P/E 347.37 1
EV/EBITDA -44.5 0
Total: 1.75

Efficiency

Title Value Grade
ROA, % 0.2949 1
ROE, % 0.3043 1
Total: 0.3333

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 716.49 10
Yield EPS, % -287.79 0
Total: 2.4



Head Job title Payment Year of birth
Dr. Steven Kafka Ph.D. CEO & Director 1969 (56 years)
Mr. Christopher E. Wolfe CFO & Sec. 1980 (45 years)

Address: United States, New York, 345 Park Avenue South - open in Google maps, open in Yandex maps